Genetic study for better Brugada diagnosis
Part of Genetic & congenital, Heart & circulation clinical trials.
This study looks at the genes of people with Brugada Syndrome to find new markers that can help doctors diagnose it more accurately. If you have Brugada Syndrome, joining could help improve understanding and care for this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with Brugada Syndrome.
- You are willing to sign a form agreeing to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for a specific type of antibody (a protein made by your immune system) that may affect the heart in people with breast or colorectal cancer. The goal is to understand if these antibodies can cause heart rhythm or function changes.
This study is collecting information from people with Brugada syndrome who are having anesthesia or sedation for any procedure. The goal is to learn more about how these medications affect people with Brugada syndrome, so doctors can provide safer care in the future.
This study looks for hidden heart rhythm problems in adults. It involves simple tests to find conditions that might otherwise go unnoticed.
This trial tests whether empagliflozin, a diabetes medication, can help people with Brugada syndrome. It aims to see if the drug can reduce the risk of dangerous heart rhythms.
This study uses your blood or genetic information to make “iPS cells,” lab-grown cells that can help researchers study inherited heart rhythm problems like LQTS, Brugada syndrome, CPVT, or early repolarization syndrome. It may help improve understanding of why these rhythms happen and guide future treatments.
This study uses detailed 3D heart mapping to find where abnormal electrical activity starts in Brugada syndrome and then performs ablation (a targeted scar or block). It’s mainly for adults who have had concerning symptoms and already have an implanted defibrillator (ICD).
Hear when a new Brugada Syndrome (BrS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.